HPV prevention and control – The way forward

HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019

(2021) Laia Bruni et al.   PREVENTIVE MEDICINE

2020 List of human papillomavirus assays Suitable for primary cervical cancer screening

(2021) M. Arbyn et al.   CLINICAL MICROBIOLOGY AND INFECTION

The development of “automated visual evaluation” for cervical cancer screening: The promise and challenges in adapting deep‐learning for clinical testing

(2021) Kanan T. Desai et al.   INTERNATIONAL JOURNAL OF CANCER

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study

(2021) Milena Falcaro et al.   LANCET

Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries

(2020) Marc Brisson et al.   LANCET

Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries

(2020) Karen Canfell et al.   LANCET

HPV-based cervical cancer screening, including self-sampling, versus screening with cytology in Argentina

(2019) Marc Arbyn et al.   Lancet Global Health

Role of HPV genotype, multiple infections and viral load on the risk of high-grade cervical neoplasia

(2019) Rachael Adcock et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis

(2019) Marc Arbyn et al.   Lancet Global Health

Human Papillomavirus DNA Methylation as a Biomarker for Cervical Precancer: Consistency across 12 Genotypes and Potential Impact on Management of HPV-Positive Women

(2018) Megan A. Clarke et al.   CLINICAL CANCER RESEARCH

Worldwide burden of cancer attributable to HPV by site, country and HPV type

(2017) Catherine de Martel et al.   INTERNATIONAL JOURNAL OF CANCER

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

(2010) Silvia de Sanjose et al.   LANCET ONCOLOGY